Literature DB >> 9914160

N-Ras induces alterations in Golgi complex architecture and in constitutive protein transport.

T Babiá1, I Ayala, F Valderrama, E Mato, M Bosch, J F Santarén, J Renau-Piqueras, J W Kok, T M Thomson, G Egea.   

Abstract

Aberrant glycosylation of proteins and lipids is a common feature of many tumor cell types, and is often accompanied by alterations in membrane traffic and an anomalous localization of Golgi-resident proteins and glycans. These observations suggest that the Golgi complex is a key organelle for at least some of the functional changes associated with malignant transformation. To gain insight into this possibility, we have analyzed changes in the structure and function of the Golgi complex induced by the conditional expression of the transforming N-Ras(K61) mutant in the NRK cell line. A remarkable and specific effect associated with this N-Ras-induced transformation was a conspicuous rearrangement of the Golgi complex into a collapsed morphology. Ultrastructural and stereological analyses demonstrated that the Golgi complex was extensively fragmented. The collapse of the Golgi complex was also accompanied by a disruption of the actin cytoskeleton. Functionally, N-Ras-transformed KT8 cells showed an increase in the constitutive protein transport from the trans-Golgi network to the cell surface, and did not induce the appearance of aberrant cell surface glycans. The Golgi complex collapse, the actin disassembly, and the increased constitutive secretion were all partially inhibited by the phospholipase A2 inhibitor 4-bromophenylacyl bromide. The results thus suggest the involvement of the actin cytoskeleton in the shape of the Golgi complex, and intracellular phospholipase A2 in its architecture and secretory function.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9914160     DOI: 10.1242/jcs.112.4.477

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  7 in total

1.  The golgi-associated COPI-coated buds and vesicles contain beta/gamma -actin.

Authors:  F Valderrama; A Luna; T Babía; J A Martinez-Menárguez; J Ballesta; H Barth; C Chaponnier; J Renau-Piqueras; G Egea
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-15       Impact factor: 11.205

2.  cdc42 regulates the exit of apical and basolateral proteins from the trans-Golgi network.

Authors:  A Müsch; D Cohen; G Kreitzer; E Rodriguez-Boulan
Journal:  EMBO J       Date:  2001-05-01       Impact factor: 11.598

3.  Golgi localization of Syne-1.

Authors:  Lisa Lucio Gough; Jun Fan; Stephen Chu; Shawn Winnick; Kenneth A Beck
Journal:  Mol Biol Cell       Date:  2003-03-07       Impact factor: 4.138

4.  Ras, an actor on many stages: posttranslational modifications, localization, and site-specified events.

Authors:  Imanol Arozarena; Fernando Calvo; Piero Crespo
Journal:  Genes Cancer       Date:  2011-03

5.  High IGFBP2 expression correlates with tumor severity in pediatric rhabdomyosarcoma.

Authors:  Lucia Tombolan; Francesca Orso; Vincenza Guzzardo; Silvia Casara; Angelica Zin; Massimo Bonora; Chiara Romualdi; Carlotta Giorgi; Gianni Bisogno; Rita Alaggio; Paolo Pinton; Cristiano De Pittà; Daniela Taverna; Angelo Rosolen; Gerolamo Lanfranchi
Journal:  Am J Pathol       Date:  2011-09-13       Impact factor: 4.307

6.  Alcohol induces Golgi fragmentation in differentiated PC12 cells by deregulating Rab1-dependent ER-to-Golgi transport.

Authors:  Mónica Tomás; María Pilar Marín; Emma Martínez-Alonso; Guillermo Esteban-Pretel; Alberto Díaz-Ruiz; Rafael Vázquez-Martínez; María M Malagón; Jaime Renau-Piqueras; José A Martínez-Menárguez
Journal:  Histochem Cell Biol       Date:  2012-05-22       Impact factor: 4.304

7.  Loss of myosin VI reduces secretion and the size of the Golgi in fibroblasts from Snell's waltzer mice.

Authors:  Claire L Warner; Abigail Stewart; J Paul Luzio; Karen P Steel; Richard T Libby; John Kendrick-Jones; Folma Buss
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.